Physician

Ammar Y Ali, M.D.

According to 2025 Medicare claims, Ammar Ali, M.D. (NPI: 1558572677) practices infectious disease in the Warren-Troy-Farmington Hills, MI market, with the plurality of this provider's patient population coming from Oakland, MI. This provider's primary affiliated billing organization is NEWLAND MEDICAL ASSOCIATES, P.C. (NPI: 1952330789; TIN: 382495445) and primary practice location at 48374-1233. Ali is affiliated with the St. John Providence ACO, LLC (ACO ID: A5417), participating under the MSSP model.

Ali's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 196 traditional Medicare patients, billed 614 HCPCS/CPT codes, and received $60,214 in Medicare payments. The top billing code was 99223 (Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes). Part D data shows 283 prescription claims across 54 beneficiaries totaling $339,803 in drug costs, led by Biktarvy (Bictegrav/Emtricit/Tenofov Ala). Open Payments data shows 2 records totaling $73. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a higher plateau to a lower plateau, from $133,790 to $60,214. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $215,648 and ending at $339,803. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	393	1,507	$133,790
2016	391	1,391	$122,612
2017	439	1,745	$160,876
2018	408	1,513	$150,424
2019	358	1,182	$113,908
2020	248	914	$87,495
2021	251	858	$77,844
2022	232	777	$72,185
2023	230	735	$74,021
2024	196	614	$60,214

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	40	127	$215,648
2016	39	195	$275,669
2017	37	131	$91,052
2018	45	136	$407,158
2019	48	185	$78,992
2020	42	224	$112,062
2021	38	174	$123,504
2022	39	162	$167,308
2023	52	335	$292,057
2024	54	283	$339,803

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	136	146	$130
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	18	40	$114
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	104	255	$95
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	11	12	$83
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	68	127	$64

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Biktarvy	Bictegrav/Emtricit/Tenofov Ala	68	2,040	$267,676
Pifeltro	Doravirine	11	330	$18,910
Ertapenem	Ertapenem Sodium	13	74	$4,796
Vancomycin Hcl	Vancomycin Hcl	13	177	$1,536
Cephalexin	Cephalexin	12	651	$196

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	2	$73	E.R. Squibb & Sons, L.L.C.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Ammar Y. Ali, M.D.?

Tedicare shows public-source Medicare data for Ammar Y. Ali, M.D. (NPI 1558572677), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ammar Y. Ali, M.D. have ACO affiliation data?

Ammar Y. Ali, M.D. is shown with ACO affiliation data for St. John Providence ACO, LLC (MSSP, ACO ID A5417).

What billing organization is linked to Ammar Y. Ali, M.D.?

Ammar Y. Ali, M.D. is linked to NEWLAND MEDICAL ASSOCIATES, P.C. (billing NPI 1952330789) in the available physician profile data.

Does Ammar Y. Ali, M.D. have Open Payments data?

Ammar Y. Ali, M.D. has 2 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.